Amneal Pharmaceuticals, Inc. Class A
(NYSE : AMRX)

( )
AMRX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
BMYBristol-Myers Squibb Company
-0.82%49.711.4%$1012.77m
PFEPfizer Inc.
-0.61%42.270.9%$1009.17m
JNJJohnson & Johnson
-1.36%128.910.6%$991.20m
MRKMerck & Co., Inc.
-0.03%75.850.6%$985.18m
ABBVAbbVie, Inc.
-0.91%88.692.2%$588.48m
LLYEli Lilly and Company
0.39%117.041.0%$522.86m
AZNAstraZeneca PLC Sponsored ADR
-0.77%36.271.3%$198.52m
NVSNovartis AG Sponsored ADR
-0.78%88.300.2%$161.04m
GSKGlaxoSmithKline plc Sponsored ADR
-0.23%38.970.2%$126.72m
NVONovo Nordisk A/S Sponsored ADR Class B
0.27%48.180.1%$70.93m
SNYSanofi Sponsored ADR
0.02%41.490.2%$38.70m
LCILannett Company, Inc.
2.09%7.8137.0%$11.76m
AKTXAkari Therapeutics Plc Sponsored ADR
-0.58%1.841.7%$0.05m
EPIXESSA Pharma Inc
3.32%4.050.1%$0.03m

Company Profile

Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It also engages in the development, manufacture and sale of branded products. The company was founded in 2017 and is headquartered in Bridgewater, NJ.